These compounds may interact with:
Arachidonate 5-lipoxygenase-activating protein
Potentially involved in: macular holes; asthma; cerebrovascular disease; atherosclerosis; coronary artery disease; cerebral infarction; liver diseases; proteinuria; neurotoxicity syndromes; stroke, ischemic; active crohn's disease; adrenocortical carcinoma; adult high grade glioma; astrocytoma, pilocytic; cutaneous lupus erythematosus; down syndrome; ependymoma; glioblastoma; group 3 medulloblastoma; interstitial cystitis
Disease data sourced from Pharos.